Skip to content

Use of intraoral camera to motivate tobacco users with oral white lesions

Intraoral Camera versus conventional methods in motivation of Tobacco Users with Leukoplakia towards cessation and treatment: A Tertiary Care-Based Randomized Controlled study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/099323
Enrollment
104
Registered
2025-12-17
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K132- Leukoplakia and other disturbancesof oral epithelium, including tongue

Interventions

Intervention1: Intraoral camera assisted tobacco cessation counselling: Tobacco cessation counselling supplemented with intraoral camera imaging provided at baseline with reinforcement sessions at mon

Sponsors

Dr Aditya Agarwal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adults aged nineteen to fifty five years with clinically diagnosed oral leukoplakia and a history of tobacco use in any form, who are willing to provide written informed consent, able to understand Hindi or English, and willing to comply with study follow up.

Exclusion criteria

Exclusion criteria: Patients with a history of oral cancer, pregnant or lactating women, individuals with severe systemic illness affecting participation, patients currently enrolled in other tobacco cessation programs, and those unwilling to provide informed consent.

Design outcomes

Primary

MeasureTime frame
Tobacco cessation status and addiction level among tobacco users with leukoplakia. Tobacco cessation will be assessed using the Importance, Readiness, and Confidence (IRC) scale, and addiction levels will be assessed using the Fagerstr m Test for Nicotine Dependence (FTND).Timepoint: baseline , 4 weeks and 8 weeks

Secondary

MeasureTime frame
Urine cotinine levelTimepoint: 24th week;Progression or regression of leukoplakia lesionsTimepoint: 4th week, 12th week, and 24th week;Treatment uptake (laser ablation)Timepoint: 4 weeks, 12 weeks, and 24 weeks

Countries

India

Contacts

Public ContactDr Aditya Agarwal

King George s Medical University, Lucknow

drmishragaurav@gmail.com9651771144

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026